2022
Variation and Disparity in the Use of Prostate Cancer Risk Stratification Tools in the United States
Laditi F, Nie J, Jones T, Leapman MS. Variation and Disparity in the Use of Prostate Cancer Risk Stratification Tools in the United States. European Urology Focus 2022, 8: 910-912. PMID: 35778364, DOI: 10.1016/j.euf.2022.06.003.Peer-Reviewed Original ResearchMeSH KeywordsBlack or African AmericanHispanic or LatinoHumansMaleProstatic NeoplasmsRisk AssessmentUnited StatesWhite PeopleConceptsProstate magnetic resonance imagingMagnetic resonance imagingWhite patientsMagnetic resonance imaging (MRI) scansRisk stratification toolLarge observational studiesResonance imaging scansGene expression testStratification toolImaging scansCancer toolProstate cancerObservational studyPractice variationModifiable sourceResonance imagingGenetic testingPatientsRacial variationGenomic testingUS studiesLow useLess useExpression testReview
2021
Racial Differences in Incident Genitourinary Cancer Cases Captured in the National Cancer Database
Wolff D, Monaghan T, Gordon D, Michelson K, Jones T, Khargi R, Smith M, Maffucci F, Kwun H, Suss N, Winer A. Racial Differences in Incident Genitourinary Cancer Cases Captured in the National Cancer Database. Medicina 2021, 57: 671. PMID: 34209546, PMCID: PMC8303448, DOI: 10.3390/medicina57070671.Peer-Reviewed Original ResearchMeSH KeywordsDatabases, FactualFemaleHumansIncidenceMaleRace FactorsTesticular NeoplasmsWhite PeopleConceptsNational Cancer DatabaseGenitourinary cancersBladder cancerCancer DatabaseProstate cancerCancer casesKidney cancerPrimary tumor locationPatient demographic factorsNew cancer diagnosesCoverage ratePenile cancerBlack patientsGenitourinary malignanciesTesticular cancerTumor locationMajor cancersHealth equity researchCancerWhite subjectsCancer diagnosisLow coverage rateWhite femalesRacial differences